Vardhman Textiles Merger & Restructuring Worth ₹77.87 Cr

Vardhman Textiles Earnings Call Transcript: Key Takeaways

Q2 FY27 yarn improved on pricing and cotton trading gains; fabric declined on weak exports and ~20% input cost inflation. Outlook is hedged and unquantified, hinging on US sentiment recovery.

Vardhman Textiles Management Change

Vardhman Textiles appointed Ravi Chauhan as Executive Vice-President effective 6 November 2026. He has over 22 years of association with the Vardhman Group.

Vardhman Textiles Q2 FY27 Results: Net Profit ₹358.8 Cr, Up 91.1% YoY

Vardhman Textiles Ltd reported revenue from operations of ₹2,866 Cr (+15.5% YoY) and net profit of ₹358.8 Cr (+91.1% YoY) for Q2 FY27.

Key figure

Net profit ₹358.8 Cr · +91.1% YoY

Vardhman Textiles Board Meeting Date

Vardhman Textiles scheduled its Board meeting for 6 November 2026. The agenda includes approval of un-audited financial results for the half-year ended 30 September 2026.

Vardhman Textiles Other Announcement

Vardhman Textiles Limited has submitted its Regulation 74(5) compliance report, confirming the dematerialization of 7,800 equity shares during the month of September 2026.

Vardhman Textiles Acquisition Worth ₹41.85 Cr

Vardhman Textiles approved a Rs. 41.85 Crore investment for a 26% stake in Serentica Renewables India 32. This captive power project includes 80 MW of wind and solar capacity.

Value

₹41.85 Cr

renewable power capacity

80.0 MW

Zydus Lifesciences Merger & Restructuring

Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.

Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr

Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.

Value

₹2.60 Cr

Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr

Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.

Value

₹1.20 Cr

Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr

Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.

Value

₹0.94 Cr

Adani Enterprises Merger & Restructuring

Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.

Kovai Medical Center and Hospital Merger & Restructuring Worth ₹0.85 Cr

Kovai Medical extended the completion deadline for the slump sale of its AHS division to a related-party trust to January 31, 2027. Cash consideration is Rs.84.54 Lakhs.

Value

₹0.85 Cr

Execution

Completion expected by 31 January 2027